Skip to main content
Premium Trial:

Request an Annual Quote

A Center for Personalizing Care

The NantHealth subsidiary of NantWorks, a company founded by the healthcare entrepreneur and former surgeon Patrick Soon-Shiong, has partnered with Blue Shield of California to create a personalized medicine center, the Los Angeles Times reports. The center will be created in conjunction with St. John's Health Center in Santa Monica. In a statement, NantWorks says that its supercomputing approach can reduce genomic analysis time from eight weeks to 47 seconds per patient while increasing accuracy.

"We believe the combination of technologies Patrick has pulled together holds the possibility of truly transforming healthcare," Blue Shield's president Paul Markovich tells the LA Times. "There is a lot of what I describe as informed trial and error when it comes to treatment now." Blue Shield is investing $3 million in the center.

Our sister publication GenomeWeb Daily News has more here.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.